We identified a differential response of SESN2 to dystrophin deficiency and HFHSD, suggesting that SESN2 is sensitive to the cellular and metabolic effects of both DMD and DI-IR. This evidence concerns the gene SESN2 and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.